methoxyhydroxyphenylglycol has been researched along with gemcitabine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, B; Meng, F; Sun, Y; Wang, J; Wei, J; Yuan, J; Zhong, Z | 1 |
1 other study(ies) available for methoxyhydroxyphenylglycol and gemcitabine
| Article | Year |
|---|---|
CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Deoxycytidine; Disulfides; Gemcitabine; Humans; Hyaluronan Receptors; Lung; Lung Neoplasms; Methoxyhydroxyphenylglycol; Micelles; Prodrugs | 2022 |